CD8A and neoplasm: While protection against Mtb or other infectious diseases by conditional single-cycle vectors still need to be demonstrated experimentally, studies in murine tumor models showed protection by MHC-Ia–restricted CD8+ T cells elicited by similarly attenuated MCMV-based vectors expressing tumor antigens (41, 54, 55).